These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 29859717)

  • 21. Occurrence, bioaccumulation and toxicological effect of drugs of abuse in aquatic ecosystem: A review.
    Chen L; Guo C; Sun Z; Xu J
    Environ Res; 2021 Sep; 200():111362. PubMed ID: 34048744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do we know about the ecotoxicological implications of the rare earth element gadolinium in aquatic ecosystems?
    Trapasso G; Chiesa S; Freitas R; Pereira E
    Sci Total Environ; 2021 Aug; 781():146273. PubMed ID: 33813143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceuticals in two watersheds in Eastern China and their ecological risks.
    Tang J; Sun J; Wang W; Yang L; Xu Y
    Environ Pollut; 2021 May; 277():116773. PubMed ID: 33640818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds.
    Camacho-Muñoz MD; Santos JL; Aparicio I; Alonso E
    J Hazard Mater; 2010 May; 177(1-3):1159-62. PubMed ID: 20122798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The antineoplastic drugs cyclophosphamide and cisplatin in the aquatic environment - Review.
    Queirós V; Azeiteiro UM; Soares AMVM; Freitas R
    J Hazard Mater; 2021 Jun; 412():125028. PubMed ID: 33951853
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human pharmaceuticals in marine mussels: Evidence of sneaky environmental hazard along Italian coasts.
    Mezzelani M; Fattorini D; Gorbi S; Nigro M; Regoli F
    Mar Environ Res; 2020 Dec; 162():105137. PubMed ID: 33010617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence, fate and effects of azoxystrobin in aquatic ecosystems: a review.
    Rodrigues ET; Lopes I; Pardal MÂ
    Environ Int; 2013 Mar; 53():18-28. PubMed ID: 23314040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ecotoxicology of human pharmaceuticals.
    Fent K; Weston AA; Caminada D
    Aquat Toxicol; 2006 Feb; 76(2):122-59. PubMed ID: 16257063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging contaminants in Belgian marine waters: single toxicant and mixture risks of pharmaceuticals.
    Claessens M; Vanhaecke L; Wille K; Janssen CR
    Mar Pollut Bull; 2013 Jun; 71(1-2):41-50. PubMed ID: 23643408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of microplastics in the aquatic environmental: distribution, transport, ecotoxicology, and toxicological mechanisms.
    Du J; Xu S; Zhou Q; Li H; Fu L; Tang J; Wang Y; Peng X; Xu Y; Du X
    Environ Sci Pollut Res Int; 2020 Apr; 27(11):11494-11505. PubMed ID: 32088821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respective contributions of diet and medium to the bioaccumulation of pharmaceutical compounds in the first levels of an aquatic trophic web.
    Orias F; Simon L; Perrodin Y
    Environ Sci Pollut Res Int; 2015 Dec; 22(24):20207-14. PubMed ID: 26304809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging challenges of the impacts of pharmaceuticals on aquatic ecosystems: A diatom perspective.
    Kock A; Glanville HC; Law AC; Stanton T; Carter LJ; Taylor JC
    Sci Total Environ; 2023 Jun; 878():162939. PubMed ID: 36934940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Overview of Analytical Methods to Determine Pharmaceutical Active Compounds in Aquatic Organisms.
    Gómez-Regalado MDC; Martín-Pozo L; Martín J; Santos JL; Aparicio I; Alonso E; Zafra-Gómez A
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence, ecotoxicological effects and risk assessment of antihypertensive pharmaceutical residues in the aquatic environment--A review.
    Godoy AA; Kummrow F; Pamplin PA
    Chemosphere; 2015 Nov; 138():281-91. PubMed ID: 26091869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential ecotoxicological impact of pharmaceutical and personal care products on humans and freshwater, based on USEtox™ characterization factors. A Spanish case study of toxicity impact scores.
    Ortiz de García S; García-Encina PA; Irusta-Mata R
    Sci Total Environ; 2017 Dec; 609():429-445. PubMed ID: 28755593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceuticals in the environment in Italy: causes, occurrence, effects and control.
    Zuccato E; Castiglioni S; Fanelli R; Reitano G; Bagnati R; Chiabrando C; Pomati F; Rossetti C; Calamari D
    Environ Sci Pollut Res Int; 2006 Jan; 13(1):15-21. PubMed ID: 16417127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.
    Quadra GR; Oliveira de Souza H; Costa RD; Fernandez MA
    Environ Sci Pollut Res Int; 2017 Jan; 24(2):1200-1218. PubMed ID: 27734317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceuticals May Disrupt Natural Chemical Information Flows and Species Interactions in Aquatic Systems: Ideas and Perspectives on a Hidden Global Change.
    Van Donk E; Peacor S; Grosser K; De Senerpont Domis LN; Lürling M
    Rev Environ Contam Toxicol; 2016; 238():91-105. PubMed ID: 26572767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human pharmaceuticals in the marine environment: Focus on exposure and biological effects in animal species.
    Fabbri E; Franzellitti S
    Environ Toxicol Chem; 2016 Apr; 35(4):799-812. PubMed ID: 26111460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.